311 results on '"Lloreta, Josep"'
Search Results
2. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights
3. Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities
4. Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
5. FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression
6. The effect of smoking on prostate cancer survival : a cohort analysis in Barcelona
7. In vivo intratumoral Epstein–Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications
8. Multiple progressive annular telangiectasias: A clinicopathological variant of cutaneous collagenous vasculopathy?
9. Primary Ciliary Dyskinesia: Clinical Criteria Indicating Ultrastructural Studies
10. Discinesia ciliar primaria: criterios clínicos de indicación de estudio ultraestructural
11. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types
12. Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms
13. A 12-Gene Expression Signature Is Associated with Aggressive Histological in Prostate Cancer: SEC14L1 and TCEB1 Genes Are Potential Markers of Progression
14. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer
15. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk
16. Epithelioid hemangioendothelioma of the cervical spine successfully treated with subtotal resection and radiotherapy
17. PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events
18. Concurrent TMPRSS2-ERG and SLC45A3-ERG Rearrangements Plus PTEN Loss Are Not Found in Low Grade Prostate Cancer and Define an Aggressive Tumor Subset
19. PROGNOSTIC VALUE OF DNA DAMAGE RESPONSE RELATED PROTEINS IN NON-MUSCLE INVASIVE BLADDER CANCER: MP45-12
20. Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas
21. Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels
22. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer
23. FGFR3 mutations in prostate cancer: association with low-grade tumors
24. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
25. KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations
26. Activación de células satélite en el músculo intercostal de pacientes con EPOC
27. Activation of Satellite Cells in the Intercostal Muscles of Patients With Chronic Obstructive Pulmonary Disease
28. Lung Cancer OncoGuia
29. RISK OF BLADDER CANCER ASSOCIATED WITH FAMILY HISTORY OF CANCER: DO LOW-PENETRANCE POLYMORPHISMS ACCOUNT FOR THE INCREASE IN RISK?: MP22-02
30. Genome-wide association study identifies multiple loci associated with bladder cancer risk
31. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease
32. Mucinous cystadenocarcinoma of the pancreas diagnosed in postpartum
33. Malignant peripheral nerve sheath tumor of the thyroid: A clinicopathological and ultrastructural study of one case
34. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish bladder cancer study and meta-analyses
35. Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: The Spanish bladder cancer study
36. Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy
37. Prediction of recurrence and nucleolar features in node-negative breast carcinoma, ductal type, grade II: An ultrastructural study
38. Plasma 25-Hydroxyvitamin D3 and Bladder Cancer Risk According to Tumor Stage and FGFR3 Status: A Mechanism-Based Epidemiological Study
39. Value of p16INK4a in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology
40. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer
41. Colorectal Cancer OncoGuia: surgical pathology report guidelines
42. A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non–muscle-invasive urothelial cell carcinoma: A prospective study
43. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3
44. Lung Cancer OncoGuia: surgical pathology report guidelines
45. Dermoscopic and Reflectance Confocal Microscopic Features of Exogenous Ochronosis
46. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis
47. Generalized cutis laxa and fibrillar glomerulopathy resulting from IgG Deposition in IgG-lambda Monoclonal Gammopathy: pulmonary hemorrhage during stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy
48. Does increased urination frequency protect against bladder cancer?
49. p53 IN BLADDER CANCER PROGNOSIS. RESULTS FROM A PROSPECTIVE MULTICENTRIC STUDY IN SPAIN: 1708
50. Acquired Mucosal Indeterminate Cell Histiocytoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.